Hypercholesterolemia, drug therapy
- Name
- Hypercholesterolemia, drug therapy
- Accession Number
- DBCAT001977
- Description
Not Available
- Drugs
Drug Drug Description Alirocumab A PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C). - Drugs & Drug Targets
Drug Target Type Alirocumab Proprotein convertase subtilisin/kexin type 9 target